niche industry
information & intelligence
on drug delivery logo

April 2011
PULMONARY & NASAL DRUG DELIVERY:
COULD INHALABLE DELIVERY BE APPROPRIATE FOR YOUR SMALL MOLECULE OR BIOTHERAPEUTIC?

DOWNLOAD COMPLETE ISSUE: LO RES PDF (3.2 MB FILE)

DOWNLOAD COMPLETE ISSUE: HI RES PDF (8.9 MB FILE)

CONTENTS:

Bringing the Patient’s Voice to Nasal Drug Delivery
Louise Righton
Global Market Development Manager
3M Health Care Limited

ARTICLE PDF

HDA - A New Pulmonary Drug Delivery Platform Can Provide for More Efficient and Safer Delivery
Mr Peter Boonen, Managing Director
Stirling Products Limited

ARTICLE PDF

SUPRAER: A New Class of Aerosol Delivery System for Biotherapeutics
Dr Donovan B Yeates, Chief Executive Officer
KAER Biotherapeutics

ARTICLE PDF

The Last Word in Assembly Solutions Just Got Even Better
Jean-François Bauer
Head of Marketing & Business Development
Mikron Automation

ARTICLE PDF

Pulmonary Drug Delivery - Simplified
Dr Andrea Leone-Bay, Vice-President, Pharmaceutical Development
Mr Chad Smutney, Senior Director, Device Technology
Mr Joseph Kocinsky, Senior Vice-President, Pharmaceutical Technology Development
MannKind Corporation

ARTICLE PDF

Laser Diffraction and Automated Imaging: Complementary Techniques for Dry-Powder Inhaler Development
Dr Paul Kippax, Product Group Manager, Micrometrics
Malvern Instruments Ltd

ARTICLE PDF

Versatility of the KHFA pMDI Valve
Mr Sergio Monti, V.A.R.I. SpA
Prof Glyn Taylor, i2c Pharmaceutical Services
Mr David Howlett, PharmaDelivery Solutions Ltd
V.A.R.I. SpA

ARTICLE PDF

Novel Advances in Rapid Manufacturing, Deployment, and Delivery of Intranasally Administered Drugs and Biologics
Mr Timothy Sullivan, President & Chief Executive Officer
Mystic Pharmaceuticals, Inc

ARTICLE PDF

DOWNLOAD COMPLETE ISSUE: LO RES PDF (3.2 MB FILE)

DOWNLOAD COMPLETE ISSUE: HI RES PDF (8.9 MB FILE)

Download the April 2011



click through to website